RICHARD V. McCLOSKEY, M.D., F.A.C.P.; JERRY SMILACK, M.D.
The diphtheria antitoxin content was determined in the following preparations obtained from four manufacturers: immune serum globulin, pertussis immune globulin, vaccinia immune globulin, and tetanus immune globulin. These were compared with diphtheria antitoxin of equine origin. None of the lots tested contained diphtheria antitoxin in sufficient concentration to allow use of the human globulins for antitoxic therapy of diphtheria. Since the incidence of diphtheria is increasing in the United States, a specific human diphtheria immune serum globulin for intravenous use should be developed. This would afford antitoxic therapy without hypersensitivity reactions, an unavoidable risk with the current equine diphtheria antitoxin.
Learn more about subscription options.
Register Now for a free account.
McCLOSKEY RV, SMILACK J. Diphtheria Antitoxin Content of Human Immune Serum Globulins. Ann Intern Med. 1972;77:757–758. doi: 10.7326/0003-4819-77-5-757
Download citation file:
Published: Ann Intern Med. 1972;77(5):757-758.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only